Sign in
4

Changes in Ownership

aTYR PHARMA INC Filed Acc 0001209191-16-113543

CEO and Director bought 2,500 shares at $3.55 ($8,875)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
MENDLEIN JOHN CEO and Director 2016-04-05 Purchase +2,500 $3.55 $8,875 248,471 D
Open-market purchases · 2,500 sh · avg $3.55 · $8,875
Loading xslF345X03/doc4.xml…